Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

WHAT'S NEW

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Feb 21 2019

Full Issue

SEC, Justice Department Probing Safety Of Johnson & Johnson Talc Powder Following Wave Of Lawsuits Over Alleged Cancer Link

A Reuters report in December revealed that the company knew for decades that small amounts of asbestos, a known carcinogen, had been occasionally found in its talc and powder products. Johnson & Johnson said that the federal inquiries "are related to news reports that included inaccurate statements and also withheld crucial information" that had already been made public.

The New York Times: U.S. Investigating Johnson & Johnson Over Baby Powder’s Safety

The Justice Department and Securities and Exchange Commission are investigating Johnson & Johnson over concerns about possible asbestos contamination of its popular baby powder and other talc-based products, the company said Wednesday. In a securities filing, Johnson & Johnson said it was “cooperating with these government inquiries and will be producing documents in response” to subpoenas it had received. In a separate statement, the company said that “the inquiries are related to news reports” about the welter of lawsuits it faces from consumers who claim its talc products caused cancers. (Hsu, 2/21)

Reuters: Johnson & Johnson Receives Federal Subpoenas Related To Baby Powder Litigation

The company said it intends to "cooperate fully with these inquiries and will continue to defend the Company in the talc-related litigation." The disclosure in Johnson & Johnson's annual report on Wednesday is the first time that the company disclosed it had received subpoenas from federal agencies regarding its talc powder products. The Justice Department declined to comment and the SEC did not immediately respond to requests for comment. (2/21)

The Wall Street Journal: Johnson & Johnson Is Subpoenaed For Talc Safety Information

The talc-powder litigation threatens J&J’s carefully cultivated image. At least 13,000 lawsuits against the company claim that use of Johnson’s Baby Powder and other talc products caused ovarian cancer and mesothelioma, as the lawsuits allege. J&J says decades of testing have shown its baby powder is safe and asbestos-free, and that it doesn’t cause cancer. (Loftus, 2/20)

The Hill: Johnson & Johnson Subpoenaed By DOJ And SEC, Company Says

Late last year, the company launched a national ad campaign defending itself following an investigation from Reuters that said the company knew for decades its talc baby powder contained traces of asbestos. (Weixel, 2/20)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF